{"id":331671,"date":"2021-04-21T03:24:28","date_gmt":"2021-04-21T08:54:28","guid":{"rendered":"http:\/\/tehelka.com\/?p=331671"},"modified":"2021-04-21T03:27:34","modified_gmt":"2021-04-21T08:57:34","slug":"covaxin-effectively-neutralises-double-mutant-strain-icmr","status":"publish","type":"post","link":"https:\/\/tehelka.com\/covaxin-effectively-neutralises-double-mutant-strain-icmr\/","title":{"rendered":"Covaxin effectively neutralises double mutant strain: ICMR"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-331676\" src=\"http:\/\/tehelka.com\/wp-content\/uploads\/2021\/04\/covaxin-rep1-1595214088.jpg\" alt=\"\" width=\"715\" height=\"402\" srcset=\"https:\/\/tehelka.com\/media\/2021\/04\/covaxin-rep1-1595214088.jpg 715w, https:\/\/tehelka.com\/media\/2021\/04\/covaxin-rep1-1595214088-300x169.jpg 300w, https:\/\/tehelka.com\/media\/2021\/04\/covaxin-rep1-1595214088-696x391.jpg 696w\" sizes=\"(max-width: 715px) 100vw, 715px\" \/><\/p>\n<p>The Indian Council of Medical Research (ICMR) said on Wednesday that Bharat Biotech&#8217;s COVID-19 vaccine, Covaxin effectively neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well.<\/p>\n<p>Bharat Biotech&#8217;s\u00a0 Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe with another 60 in the process.<\/p>\n<p>In a tweet ICMR said, &#8220;ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well,&#8221;<br \/>\nICMR-National Institute of Virology has successfully isolated and cultured multiple variants of concern of SARS-CoV-2 virus: B.1.1.7 (the UK variant), B.1.1.28 (Brazil variant ) and B.1.351 (South Africa variant).<\/p>\n<p>ICMR-NIV has demonstrated the neutralisation potential of Covaxin against the UK variant and Brazil variant, the apex health research body said.<\/p>\n<p>ICMR-NIV recently has been successful in isolating and culturing the double mutant strain B.1.617 SARS-CoV-2 identified in certain regions of India and several other countries, the ICMR stated.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Indian Council of Medical Research (ICMR) said on Wednesday that Bharat Biotech&#8217;s COVID-19 vaccine, Covaxin effectively neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well. Bharat Biotech&#8217;s\u00a0 Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe with another [&hellip;]<\/p>\n","protected":false},"author":59,"featured_media":331676,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[482,36],"tags":[13159,13157,9469,13995],"_links":{"self":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/331671"}],"collection":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/comments?post=331671"}],"version-history":[{"count":3,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/331671\/revisions"}],"predecessor-version":[{"id":331677,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/331671\/revisions\/331677"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/media\/331676"}],"wp:attachment":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/media?parent=331671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/categories?post=331671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/tags?post=331671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}